Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kit C B Roes

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
American Heart Journal|March 1, 2014
The effect of renal denervation added to standard pharmacologic treatment versus standard pharmacologic treatment alone in patients with resistant hypertension: rationale and design of the SYMPATHY trialEva E Vink, Esther de Beus, Rosa L de Jager, et al.
Statistics in Biopharmaceutical Research|October 23, 2025
On the Two-Step Hybrid Design for Augmenting Randomized Trials Using Real-World DataJiapeng Xu, Ruben P A van Eijk, Alicia Ellis, et al.
Psychiatry Research|January 5, 2023
Gender differences in the response to antipsychotic medication in patients with schizophrenia: An individual patient data meta-analysis of placebo-controlled studiesBram W C Storosum, Taina Mattila, Tamar D Wohlfarth, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2016
Methodological comparison of marginal structural model, time-varying Cox regression, and propensity score methods: the example of antidepressant use and the risk of hip fractureM Sanni Ali, Rolf H H Groenwold, Svetlana V Belitser, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 12, 2019
Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trialsRuben P A van Eijk, Stavros Nikolakopoulos, Kit C B Roes, et al.
The Lancet. Respiratory Medicine|December 8, 2024
Augmenting clinical trials in asthma through digital technology, decentralised designs, and person-centric endpoints: opportunities and challengesJob F M van Boven, Richard W Costello, Kit C B Roes, et al.
Neurology|January 28, 2021
Systematic Review of N-of-1 Studies in Rare Genetic Neurodevelopmental Disorders: The Power of 1Annelieke R Müller, Marion M M G Brands, Peter M van de Ven, et al.
Neurology|October 26, 2018
Multimodal nocturnal seizure detection in a residential care setting: A long-term prospective trialJohan Arends, Roland D Thijs, Thea Gutter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 12, 2023
TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocolMiranda P Steenbeek, Majke H D van Bommel, Joanna intHout, et al.
Lancet (London, England)|November 9, 2010
Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trialMaarten M J van Eijk, Kit C B Roes, Marina L H Honing, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
American Heart Journal|March 1, 2014
The effect of renal denervation added to standard pharmacologic treatment versus standard pharmacologic treatment alone in patients with resistant hypertension: rationale and design of the SYMPATHY trialEva E Vink, Esther de Beus, Rosa L de Jager, et al.
Statistics in Biopharmaceutical Research|October 23, 2025
On the Two-Step Hybrid Design for Augmenting Randomized Trials Using Real-World DataJiapeng Xu, Ruben P A van Eijk, Alicia Ellis, et al.
Psychiatry Research|January 5, 2023
Gender differences in the response to antipsychotic medication in patients with schizophrenia: An individual patient data meta-analysis of placebo-controlled studiesBram W C Storosum, Taina Mattila, Tamar D Wohlfarth, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2016
Methodological comparison of marginal structural model, time-varying Cox regression, and propensity score methods: the example of antidepressant use and the risk of hip fractureM Sanni Ali, Rolf H H Groenwold, Svetlana V Belitser, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 12, 2019
Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trialsRuben P A van Eijk, Stavros Nikolakopoulos, Kit C B Roes, et al.
The Lancet. Respiratory Medicine|December 8, 2024
Augmenting clinical trials in asthma through digital technology, decentralised designs, and person-centric endpoints: opportunities and challengesJob F M van Boven, Richard W Costello, Kit C B Roes, et al.
Neurology|January 28, 2021
Systematic Review of N-of-1 Studies in Rare Genetic Neurodevelopmental Disorders: The Power of 1Annelieke R Müller, Marion M M G Brands, Peter M van de Ven, et al.
Neurology|October 26, 2018
Multimodal nocturnal seizure detection in a residential care setting: A long-term prospective trialJohan Arends, Roland D Thijs, Thea Gutter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 12, 2023
TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocolMiranda P Steenbeek, Majke H D van Bommel, Joanna intHout, et al.
Lancet (London, England)|November 9, 2010
Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trialMaarten M J van Eijk, Kit C B Roes, Marina L H Honing, et al.
Pageof 11